サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1801047

感染管理の世界市場レポート：タイプ、エンドユーザー、地域別（2025年～2033年）

Infection Control Market Report by Type (Equipment, Services, Consumables), End User (Hospitals and Clinics, Medical Device Companies, Clinical Laboratories, Pharmaceutical Companies, and Others), and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 121 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=149.25円
感染管理の世界市場レポート：タイプ、エンドユーザー、地域別（2025年～2033年）
出版日: 2025年08月01日
発行: IMARC
ページ情報: 英文 121 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の感染管理の市場規模は、2024年に281億米ドルに達しました。IMARC Groupは、今後、2033年には497億米ドルに達し、2025～2033年の成長率（CAGR）は6.22％になると予測しています。北米が市場を独占している理由は、強固なヘルスケアインフラと滅菌・消毒技術の普及にあります。さらに、診断機器や感染管理機器の急速な技術進歩、獣医や動物医療現場での需要の増加、感染症予防の研究開発の高まり、医療関連感染（HAI）予防への関心の高まりなどが、市場成長を後押しする要因となっています。

一般市民や医療機関の衛生・安全に対する意識はかなり高まっています。ヘルスケア提供者は、二次汚染を避けるために滅菌と衛生を重視しています。この意識は患者にも広がり、医療機関がより多くのリソースを感染管理に割り当てる動機となっています。より安全な環境を求める動きは、業界における製品やプロトコルの強化の必要性を一貫して後押ししています。さらに、消毒ツールや消耗品の進歩は、その有効性と使いやすさの両方を向上させています。自動化された滅菌システム、強化された薬剤処方、リアルタイムのモニタリング・ツールは、今や容易に利用できます。これらの技術革新は、結果を改善すると同時に、労力と長期的経費を削減し、現代のヘルスケア事業にとって魅力的な投資となっています。これに加えて、待機手術や緊急手術の増加により、無菌環境の必要性が高まっています。手術室では、さまざまな備品や器具を使った厳密な対策が必要です。手術件数の増加に伴い、均一な感染管理の必要性が高まり、ヘルスケア機関にとって重要な分野となっています。

感染管理市場の動向：

高齢者人口の増加

感染管理市場の形成に重要な役割を果たす、世界の高齢者人口の増加が顕著になっています。世界保健機関（WHO）の予測によると、2030年には世界の6人に1人が60歳以上になり、世界の高齢者人口は2020年の10億人から2030年には約14億人に増加すると予想されています。2050年には、この数字は約21億人になると予想されています。高齢者は一般的に免疫反応が弱く、感染症にかかりやすくなるため、このような人口動態の変化はヘルスケアシステムに直接影響を及ぼします。その結果、病院、高齢者介護施設、長期介護施設における厳格な感染管理対策の必要性は一貫して高まっています。厳格な衛生基準を守り、最先端の滅菌法を導入することは、この年齢層の管理には欠かせません。これらの要因は、感染管理市場の予測にさらにプラスの影響を与えています。

医療関連感染（HAI）の有病率の上昇

さまざまな地域の病院や臨床環境における医療関連感染（HAI）の頻度の増加は、重要な問題として浮上しており、効率的な感染管理戦略の必要性を大きく後押ししています。手術部位感染、カテーテル関連感染、人工呼吸器関連肺炎など、頻繁に発生するHAIは、患者にとって重大な健康上の危険であり、入院期間の延長、医療費の増大、罹患率の上昇につながります。欧州疾病予防管理センター（European Centre for Disease Prevention and Control）の発表によると、EU/EEAでは毎年430万人近くの病院患者が少なくとも1回はHAIに感染しています。この気になる統計は、感染予防対策の改善と最先端の消毒・滅菌技術の導入の必要性を強調しています。ヘルスケア提供者は、患者の安全を保証し、厳格な規制要件を遵守するために、感染管理製品にリソースを徐々に割り当てています。感染率低下への関心の高まりが、感染管理業界の成長を強化しています。

外来サービス産業の拡大

外来患者向けサービスへの移行が進んでいることが、感染管理製品や技術の需要を促進する大きな要因となっています。外来患者ケアセンターは、一晩入院することなく医療サービスを提供し、その利便性、手頃な価格、アクセスのしやすさから人気が高まっています。IMARC Groupの報告によると、世界の外来サービス市場は2023年に3兆8,000億米ドルの評価額を達成し、2024年～2032年のCAGRは5.7%で、2032年までに6兆3,000億米ドルに拡大すると予想されています。この拡大の結果、外来で治療を受ける患者数が増加しており、厳格な感染管理対策の必要性が高まっています。患者の入れ替わりが激しいこと、治療サイクルが早いこと、二次汚染を避ける必要があることから、これらの施設では信頼性の高い滅菌、表面消毒、個人保護対策が求められています。外来患者における安全性と規制遵守の重視の高まりが、感染管理市場の収益を押し上げると予測されています。

感染管理市場の成長促進要因：

技術の進歩と製品イノベーション

消毒・滅菌技術の進歩は感染管理市場を変革し、その精度、効率性、変化する臨床ニーズへの適合性を高めています。材料、自動化システム、化学物質、監視プラットフォームの進歩により、感染管理の信頼性と安全性が向上しています。その顕著な例が、熱に敏感な手術器具のために特別に設計された低温VH2O2滅菌器であるGetingeのPoladus 150の2024年の導入です。この製品は、無菌供給ユニットのプロセスを最適化しながら、医療関連感染を最小限に抑えるよう設計された最先端の交差汚染防止技術を特徴としています。このシステムはまた、デジタル・プラットフォームと接続し、病院での再処理におけるトレーサビリティと作業効率を向上させました。このような技術革新により、ヘルスケア担当者は滅菌手順を均一化し、ミスを減らしながら実行できるようになります。自動化、追跡可能なシステム、直感的なインターフェイスに焦点を当てることで、労働集約的な作業を最小限に抑え、規制の遵守を強化しています。医療従事者の間で、こうした技術のコスト面や安全面での利点に対する認識が高まるにつれ、その導入が加速しています。

公衆衛生キャンペーンと政府の取り組み

政府が主導する公衆衛生キャンペーンや政策イニシアチブは、感染管理対策の強化に不可欠です。これらのイニシアチブは、衛生に関する意識を高め、抗菌薬の責任ある使用を奨励し、臨床および地域環境におけるベストプラクティスを提唱します。行政機関は、公立病院における感染管理システムの強化、アドヒアランスへのインセンティブの提供、感染パターンを追跡するサーベイランスの取り組みに、頻繁にリソースを割り当てています。ヘルスケアの国家戦略では、感染予防を重要な目標として優先させ、医療機関がより広範な保健医療目標に沿ったものとなるよう配慮しています。ヘルスケア専門家と一般市民の双方を対象とした教育的アウトリーチは、感染リスクの低減に役立つ行動修正を強化します。このようなキャンペーンはまた、消毒薬、滅菌装置、防護具など、標準化されたアイテムの需要を高めます。このような取り組みは、特に意識とインフラがまだ発展途上にある開発途上地域において、継続的な需要を生み出すと同時に、公共の安全を強化するものです。

産業界の協力

医療機器メーカーとヘルスケア利害関係者との協業は、感染管理市場の拡大を促進する上で不可欠です。このような連携は、特に感染予防など、ヘルスケアにおける重要な課題に取り組む最先端技術の認知、教育、利用を促進します。最近の例としては、インドで開催されたCRITICARE 2025におけるBactiguardとBDの共同取り組みがあり、両組織は特に集中治療環境における医療関連感染（HAI）と抗菌薬耐性（AMR）への取り組みの重要性を強調しました。イベントを通じて、臨床セッションでは、カテーテル関連尿路感染症（CAUTI）の減少や責任ある抗生物質の使用促進におけるバクティガードコーティングカテーテルの利点が強調されました。BDはまた、インド市場におけるこれらの最先端デバイスの発売が間近に迫っていることを明らかにしました。このようなイニシアチブは、大きなニーズを持つ地域に先進技術を導入するだけでなく、世界の感染管理目標の推進、患者の安全性の向上、市場アクセスの拡大における業界パートナーシップの重要性を強化しています。

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 予測手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 世界の感染管理市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：タイプ別

  • 装置
    • 主なタイプ
      • 消毒装置
        • ワッシャー
        • フラッシャー
        • 超音波洗浄機
      • 滅菌装置
        • 加熱滅菌
        • 低温滅菌
        • 放射線滅菌
        • 濾過による滅菌
      • その他
  • サービス
    • 主なタイプ
      • 委託滅菌
        • ETO滅菌
        • ガンマ線滅菌
        • 電子ビーム滅菌
        • 蒸気滅菌
      • 感染性廃棄物の処分
  • 消耗品
    • 主なタイプ
      • 消毒剤
      • 滅菌消耗品
      • 個人用保護具
      • その他

第7章 市場内訳：エンドユーザー別

  • 病院と診療所
  • 医療機器企業
  • 臨床検査室
  • 製薬会社
  • その他

第8章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ

第9章 SWOT分析

第10章 バリューチェーン分析

第11章 ポーターのファイブフォース分析

第12章 価格分析

第13章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • 3M Company
    • Advanced Sterlization Products Services Inc.（Fortive Corporation）
    • Belimed AG（Metall Zug）
    • Cantel Medical Corp.
    • Getinge AB
    • Matachana
    • Metrex Research LLC（Envista Holdings and Sybron Dental Specialities Inc）
    • MMM Munchener Medizin Mechanik GmbH
    • Pal International
    • Sterigenics U.S. LLC（Sotera Health Holdings LLC）
    • Steris Corporation
    • TSO3 Inc.（Stryker Corporation）
図表

List of Figures

  • Figure 1: Global: Infection Control Market: Major Drivers and Challenges
  • Figure 2: Global: Infection Control Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Infection Control Market: Breakup by Type (in %), 2024
  • Figure 4: Global: Infection Control Market: Breakup by End User (in %), 2024
  • Figure 5: Global: Infection Control Market: Breakup by Region (in %), 2024
  • Figure 6: Global: Infection Control Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 7: Global: Infection Control (Equipment) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 8: Global: Infection Control (Equipment) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 9: Global: Infection Control (Services) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Infection Control (Services) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Infection Control (Consumables) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Infection Control (Consumables) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Infection Control (Hospitals and Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Infection Control (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Infection Control (Medical Device Companies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Infection Control (Medical Device Companies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Infection Control (Clinical Laboratories) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Infection Control (Clinical Laboratories) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Infection Control (Pharmaceutical Companies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Infection Control (Pharmaceutical Companies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Infection Control (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Infection Control (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: North America: Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: North America: Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: United States: Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: United States: Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Canada: Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Canada: Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Asia Pacific: Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Asia Pacific: Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: China: Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: China: Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Japan: Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Japan: Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: India: Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: India: Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: South Korea: Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: South Korea: Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Australia: Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Australia: Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Indonesia: Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Indonesia: Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Others: Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Others: Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Europe: Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Europe: Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Germany: Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Germany: Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: France: Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: France: Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: United Kingdom: Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: United Kingdom: Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Italy: Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Italy: Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Spain: Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Spain: Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Russia: Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Russia: Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Others: Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Others: Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Latin America: Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Latin America: Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Brazil: Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Brazil: Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Mexico: Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Mexico: Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Others: Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Others: Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Middle East and Africa: Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Middle East and Africa: Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Global: Infection Control Industry: SWOT Analysis
  • Figure 72: Global: Infection Control Industry: Value Chain Analysis
  • Figure 73: Global: Infection Control Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Infection Control Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Infection Control Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Infection Control Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 4: Global: Infection Control Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 5: Global: Infection Control Market: Competitive Structure
  • Table 6: Global: Infection Control Market: Key Players
目次
Product Code: SR112025A2509

The global infection control market size reached USD 28.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 49.7 Billion by 2033, exhibiting a growth rate (CAGR) of 6.22% during 2025-2033. North America dominates the market because of robust healthcare infrastructure and widespread adoption of sterilization and disinfection technologies. Moreover, the rapid technological advancements in diagnostic and infection control equipment, the increasing demand in veterinary and animal care settings, rising R&D in infectious disease prevention, and the growing focus on preventing healthcare-associated infections (HAIs) are some of the factors propelling the market growth.

Awareness about hygiene and safety among the public and institutions is rising considerably. Healthcare providers emphasize sterilization and hygiene to avoid cross-contamination. This consciousness spreads to patients, motivating institutions to allocate more resources to infection control. The drive for safer surroundings is consistently driving the need for enhanced products and protocols in the industry. Furthermore, ongoing advancements in disinfection tools and supplies are enhancing both their efficacy and user-friendliness. Automated sterilization systems, enhanced chemical formulations, and real-time monitoring tools are now easily available. These innovations improve results while lowering labor and long-term expenses, making them appealing investments for contemporary healthcare operations. Besides this, the increase in elective and emergency surgeries results in a greater need for sterile environments. Surgical suites necessitate rigorous infection control measures, involving a wide array of supplies and instruments. With the rise in surgical volumes, the necessity for uniform infection control grows, making it a key area of focus for healthcare institutions.

Infection Control Market Trends:

Increasing Geriatric Population

There has been a notable rise in the global geriatric population, which plays a crucial role in shaping the infection control market. As projected by the World Health Organization (WHO), by the year 2030, one in six people globally will be aged 60 and above, with the worldwide senior population anticipated to rise from 1 billion in 2020 to approximately 1.4 billion by 2030. By the year 2050, this figure is expected to be around 2.1 billion. This change in demographics directly affects healthcare systems, as older individuals commonly exhibit weaker immune responses and increased vulnerability to infections. As a result, the need for strict infection control measures in hospitals, nursing homes, and long-term care facilities is growing consistently. Upholding rigorous hygiene standards and implementing cutting-edge sterilization methods are crucial in managing this age demographic. These factors further positively influence the infection control market forecast.

Rising Prevalence of Healthcare-Associated Infections (HAI)

The growing frequency of healthcare-associated infections (HAIs) in hospitals and clinical environments in different areas is emerging as a significant issue, considerably driving the need for efficient infection control strategies. Frequent forms of HAIs, including surgical site infections, catheter-related infections, and ventilator-related pneumonia, represent significant health dangers to patients and lead to prolonged hospitalizations, rising healthcare costs, and elevated morbidity rates. A publication from the European Centre for Disease Prevention and Control indicates that nearly 4.3 million hospital patients in the EU/EEA acquire at least one HAI each year. This concerning statistic highlights the critical necessity for improved infection prevention measures and the implementation of cutting-edge disinfection and sterilization technologies. Healthcare providers are progressively allocating resources to infection control products to guarantee patient safety and adhere to rigorous regulatory requirements. The increasing focus on lowering infection rates is strengthening the growth of the infection control industry.

Expanding Ambulatory Services Industry

The increasing transition towards outpatient services is becoming a major factor in driving the demand for infection control products and technologies. These outpatient care centers, providing medical services without the need for overnight hospital admissions, are becoming more popular because of their convenience, affordability, and accessibility. As reported by IMARC Group, the worldwide ambulatory services market attained a valuation of US$ 3.8 Trillion in 2023 and is expected to expand to US$ 6.3 Trillion by 2032, with a compound annual growth rate (CAGR) of 5.7% from 2024 to 2032. As a result of this expansion, the number of patients receiving care in outpatient settings is increasing, which heightens the need for strict infection control measures. Due to high patient turnover, swift treatment cycles, and the necessity to avert cross-contamination, these facilities demand dependable sterilization, surface disinfection, and personal protective measures. The rising emphasis on safety and regulatory adherence in outpatient settings is anticipated to boost the infection control market revenue.

Infection Control Market Growth Drivers:

Technological Advancement and Product Innovation

Advancements in technology for disinfection and sterilization are transformed the infection control market, enhancing its precision, efficiency, and compatibility with changing clinical needs. Advancements in materials, automated systems, chemical substances, and monitoring platforms are enhancing reliability and safety in infection control. A prominent instance is the 2024 introduction of Getinge's Poladus 150, a low-temperature VH2O2 sterilizer designed specifically for heat-sensitive surgical tools. It featured cutting-edge cross-contamination prevention technology designed to minimize healthcare-related infections while optimizing processes in sterile supply units. The system also connected with digital platforms, providing improved traceability and operational effectiveness during hospital reprocessing. Such innovations enable healthcare personnel to execute sterilization procedures with improved uniformity and reduced mistakes. The focus on automation, traceable systems, and intuitive interfaces is minimizing labor-heavy tasks and enhanced adherence to regulations. With increasing awareness among healthcare providers regarding the cost and safety advantages of these technologies, their adoption is accelerating.

Public Health Campaigns and Government Initiatives

Public health campaigns and policy initiatives led by the government are vital in enhancing infection control measures. These initiatives enhance awareness about hygiene, encourage responsible use of antimicrobials, and advocate for best practices in clinical and community environments. Governing bodies frequently assign resources to enhance infection control systems in public hospitals, provide incentives for adherence, and back surveillance initiatives that track infection patterns. National healthcare strategies are progressively prioritizing infection prevention as a key goal, making sure that institutions align with wider health objectives. Educational outreach aimed at both healthcare professionals and the general public reinforces behavior modifications that help lower transmission risks. These campaigns also increase the demand for standardized items, such as disinfectants, sterilization devices, and protective gear. These initiatives enhance public safety while generating ongoing demand, especially in developing areas where awareness and infrastructure are still growing.

Industry Collaboration

Collaborative efforts between manufacturers of medical devices and healthcare stakeholders are essential in promoting the expansion of the infection control market. These collaborations promote awareness, education, and availability of cutting-edge technologies that tackle critical healthcare issues, especially in preventing infections. A recent instance is the collaborative effort by Bactiguard and BD at CRITICARE 2025 in India, where both organizations highlighted the significance of addressing healthcare-associated infections (HAIs) and antimicrobial resistance (AMR), especially in intensive care settings. Throughout the event, clinical sessions emphasized the advantages of Bactiguard-coated catheters in decreasing catheter-associated urinary tract infections (CAUTI) and promoting responsible antibiotic usage. BD has also revealed the imminent release of these cutting-edge devices in the Indian market. These initiatives not only introduce advanced technologies to areas with significant needs but also strengthen the importance of industry partnerships in promoting worldwide infection control objectives, improving patient safety, and broadening market access.

Global Infection Control Industry Segmentation:

Breakup by Type:

  • Equipment
    • Disinfectors
    • Washers
    • Flushers
    • Ultrasonic Cleaners
    • Sterilization Equipment
    • Heat Sterilization
    • Low Temperature Sterilization
    • Radiation Sterilization
    • Filtration-Based Sterilization
    • Others
  • Services
    • Contract Sterilization
    • ETO Sterilization
    • Gamma Sterilization
    • E-Beam Sterilization
    • Steam Sterilization
    • Infectious Waste Disposal
  • Consumables
    • Disinfectants
    • Sterilization Consumables
    • Personal Protective Equipment
    • Others

Consumables dominate the market

According to the infection control market outlook, the consumables segment, including disinfectants, sterilization consumables, personal protective equipment (PPE), and other related products, is the largest market segment in the industry. These consumables play a critical role in preventing and controlling the spread of infections across various sectors, such as healthcare, food processing, and public spaces. Disinfectants are vital in healthcare facilities, laboratories, and public spaces to eliminate harmful pathogens on surfaces and minimize the risk of infections. Sterilization consumables, like autoclave bags and indicator tapes, are indispensable in maintaining sterile medical instruments and equipment conditions.

Breakup by End User:

  • Hospitals and Clinics
  • Medical Device Companies
  • Clinical Laboratories
  • Pharmaceutical Companies
  • Others

Hospitals and clinics dominate the market

According to the infection control market overview, the hospitals and clinics segment emerged as the largest market share holder in the industry, reflecting the critical role of infection prevention measures in healthcare settings. Hospitals and clinics are high-risk environments where vulnerable patients, healthcare professionals, and visitors come into close contact, making them susceptible to infectious diseases. Infection control is of utmost importance in these settings to curb the spread of healthcare-associated infections (HAIs) and safeguard patient safety. Strict protocols, including hand hygiene, sterilization of medical equipment, and the use of personal protective equipment (PPE), are integral to maintaining a safe and sterile environment. Besides this, with a growing focus on patient care, hospital accreditation, and regulatory compliance, the demand for these solutions in hospitals and clinics remains robust. As healthcare facilities strive to enhance infection prevention measures and reduce the burden of HAIs, the hospitals and clinics segment is expected to continue leading the market.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America exhibits a clear dominance, accounting for the largest infection control market share

The report has also provided a comprehensive analysis of all the major regional markets, which includes North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Russia, and Others); Europe (Germany, France, the United Kingdom, Italy, Spain, and Others); Latin America (Brazil, Mexico, and Others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

According to the infection control market statistics, North America, comprising the United States and Canada, dominate the market, which can be attributed to several key factors driving its growth. The region's significant aging population contributes to the rising demand for infection control measures. For instance, according to an article published by the Population Reference Bureau, the number of people in the United States aged 65 and older is expected to rise from 58 million in 2022 to 82 million by 2050 (a 47% increase), with the 65-and-over age group accounting for 17% to 23% of the overall population. Moreover, the region's technologically advanced healthcare infrastructure fosters the adoption of innovative infection control solutions, including advanced disinfectants, sterilization technologies, and smart medical devices.

Competitive Landscape:

Top companies catalyze the market by introducing innovative solutions and technologies to combat infectious diseases. These companies invest heavily in research and development, creating cutting-edge disinfection and sterilization products that effectively prevent the spread of infections. Their commitment to maintaining stringent quality standards and adherence to regulatory guidelines instills trust among healthcare providers, bolstering their market presence. Moreover, these companies actively engage in educational programs and awareness campaigns, emphasizing the importance of infection prevention and control measures. Continued efforts to expand their global footprint through strategic collaborations and acquisitions further fuel market growth. They address environmental concerns and attract environmentally-conscious consumers by prioritizing sustainability and eco-friendly practices.

The infection control market research report has provided a comprehensive analysis of the competitive landscape in the infection control market. Detailed profiles of all major companies have also been provided.

  • 3M Company
  • Advanced Sterlization Products Services Inc. (Fortive Corporation)
  • Belimed AG (Metall Zug)
  • Cantel Medical Corp.
  • Getinge AB
  • Matachana
  • Metrex Research LLC (Envista Holdings and Sybron Dental Specialities Inc.)
  • MMM Munchener Medizin Mechanik GmbH
  • Pal International
  • Sterigenics U.S. LLC (Sotera Health Holdings LLC)
  • Steris Corporation
  • TSO3 Inc. (Stryker Corporation)

Key Questions Answered in This Report:

  • How has the global infection control market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global infection control market?
  • What is the impact of each driver, restraint, and opportunity on the global infection control market?
  • What are the key regional markets?
  • Which countries represent the most attractive infection control market?
  • What is the breakup of the market based on the type?
  • Which is the most attractive type in the global infection control market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the global infection control market?
  • What is the competitive structure of the global infection control market?
  • Who are the key players/companies in the global infection control market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Infection Control Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Equipment
    • 6.1.1 Market Trends
    • 6.1.2 Major Types
      • 6.1.2.1 Disinfectors
        • 6.1.2.1.1 Washers
        • 6.1.2.1.2 Flushers
        • 6.1.2.1.3 Ultrasonic Cleaners
      • 6.1.2.2 Sterilization Equipment
        • 6.1.2.2.1 Heat Sterilization
        • 6.1.2.2.2 Low Temperature Sterilization
        • 6.1.2.2.3 Radiation Sterilization
        • 6.1.2.2.4 Filtration-Based Sterilization
      • 6.1.2.3 Others
    • 6.1.3 Market Forecast
  • 6.2 Services
    • 6.2.1 Market Trends
    • 6.2.2 Major Types
      • 6.2.2.1 Contract Sterilization
        • 6.2.2.1.1 ETO Sterilization
        • 6.2.2.1.2 Gamma Sterilization
        • 6.2.2.1.3 E-Beam Sterilization
        • 6.2.2.1.4 Steam Sterilization
      • 6.2.2.2 Infectious Waste Disposal
    • 6.2.3 Market Forecast
  • 6.3 Consumables
    • 6.3.1 Market Trends
    • 6.3.2 Major Types
      • 6.3.2.1 Disinfectants
      • 6.3.2.2 Sterilization Consumables
      • 6.3.2.3 Personal Protective Equipment
      • 6.3.2.4 Others
    • 6.3.3 Market Forecast

7 Market Breakup by End User

  • 7.1 Hospitals and Clinics
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Medical Device Companies
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Clinical Laboratories
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Pharmaceutical Companies
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 3M Company
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Advanced Sterlization Products Services Inc. (Fortive Corporation)
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 Belimed AG (Metall Zug)
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
    • 13.3.4 Cantel Medical Corp.
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 Getinge AB
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
      • 13.3.5.4 SWOT Analysis
    • 13.3.6 Matachana
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
    • 13.3.7 Metrex Research LLC (Envista Holdings and Sybron Dental Specialities Inc)
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
    • 13.3.8 MMM Munchener Medizin Mechanik GmbH
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
    • 13.3.9 Pal International
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
    • 13.3.10 Sterigenics U.S. LLC (Sotera Health Holdings LLC)
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
    • 13.3.11 Steris Corporation
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio
    • 13.3.12 TSO3 Inc. (Stryker Corporation)
      • 13.3.12.1 Company Overview
      • 13.3.12.2 Product Portfolio